The phase 3 NRG GU-005 trial did not show a DFS benefit for SBRT vs IMRT in intermediate-risk prostate cancer, but SBRT decreased rectal toxicity. Stereotactic body radiation therapy (SBRT) preserves ...

Prostate cancer is the most common solid tumor in male patients. Roughly 70,000 U.S. adults each year are diagnosed with intermediate-risk disease confined to the prostate, for which radiation therapy ...

TO RESPOND TO TREATMENT, AND PRESIDENT BIDEN’S DIAGNOSIS HAS A LOT OF PEOPLE ASKING QUESTIONS ABOUT PROSTATE CANCER. AND EARLIER TODAY ON KCRA THREE, WE ASKED OUR VIEWERS FOR SOME OF THEIR QUESTIONS ...

In prostate cancer, prostate brachytherapy boost improves biochemical failure at 10 years but does not prolong long-term OS ...

FORMER PRESIDENT JOSEPH R. Biden has been diagnosed with Stage 4 prostate cancer, his office announced The cancer has spread to his bones, as it commonly does in more aggressive forms. It is generally ...